GlaxoSmithKline and Novartis have made another admission in a case brought by the ACCC alleging the drug giants made misleading claims in marketing their Voltaren Osteo Gel and Voltaren Emulgel pain relief products.
Class action firm Maurice Blackburn is calling for investors to join a lawsuit against Retail Food Group accusing the franchise giant of misleading the market about the long-term viability of its business model.
The Fair Work Commission has given the go-ahead to the proposed merger of the Construction, Forestry, Mining and Energy Union with two other unions, a marriage that will result in a powerhouse union with over 144,000 members.
Volkswagen lost its bid Tuesday to exclude evidence from its own expert witness it claims has gone off script, an early blow to the car maker in the massive trial alleging it installed dual-mode software in diesel vehicles to cheat on emissions tests.
Litigation funder LCM said Monday it had agreed to finance a $100 million class action on behalf of fishing operators and seafood suppliers who claim they lost their livelihoods after dredging at Gladstone Port in southern Queensland.
Canadian dairy giant Saputo said Monday it is considering selling a milk plant in Victoria to smooth regulatory approval of its proposed $1.3 billion deal to buy Murray Goulburn.
Teleco provider Activ8me has run afoul of the law by falsely claiming the ACCC gave its internet services the thumbs up, the consumer regulator said Monday.
Sydney’s iconic Taronga Zoo will bare its teeth in court Tuesday for the first hearing in its trade mark battle against the creators of Sydney Zoo, a wildlife reserve in Darling Harbour.
The Reject Shop has agreed to pay a penalty of $140,000 and will refund customers who purchased projectile toys that violate consumer protection laws.
Reckitt Benckiser has filed an appeal against GlaxoSmithKline, after a judge found the consumer goods giant misled consumers with claims that Nurofen was a more effective pain killer than its rival’s Panadol and ordered it to pay all of GlaxoSmithKline’s legal bill.